MURA
Price
$4.00
Change
+$0.31 (+8.40%)
Updated
Jan 17 closing price
Capitalization
68.24M
72 days until earnings call
NUVB
Price
$2.51
Change
-$0.03 (-1.18%)
Updated
Jan 17 closing price
Capitalization
844.78M
39 days until earnings call
Ad is loading...

MURA vs NUVB

Header iconMURA vs NUVB Comparison
Open Charts MURA vs NUVBBanner chart's image
Mural Oncology
Price$4.00
Change+$0.31 (+8.40%)
Volume$342.99K
Capitalization68.24M
Nuvation Bio
Price$2.51
Change-$0.03 (-1.18%)
Volume$2.38M
Capitalization844.78M
MURA vs NUVB Comparison Chart
Loading...
MURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MURA vs. NUVB commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MURA is a Hold and NUVB is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (MURA: $4.00 vs. NUVB: $2.51)
Brand notoriety: MURA and NUVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MURA: 144% vs. NUVB: 90%
Market capitalization -- MURA: $68.24M vs. NUVB: $844.78M
MURA [@Biotechnology] is valued at $68.24M. NUVB’s [@Biotechnology] market capitalization is $844.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MURA’s FA Score shows that 1 FA rating(s) are green whileNUVB’s FA Score has 0 green FA rating(s).

  • MURA’s FA Score: 1 green, 4 red.
  • NUVB’s FA Score: 0 green, 5 red.
According to our system of comparison, MURA is a better buy in the long-term than NUVB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MURA’s TA Score shows that 5 TA indicator(s) are bullish while NUVB’s TA Score has 3 bullish TA indicator(s).

  • MURA’s TA Score: 5 bullish, 5 bearish.
  • NUVB’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, MURA is a better buy in the short-term than NUVB.

Price Growth

MURA (@Biotechnology) experienced а +2.83% price change this week, while NUVB (@Biotechnology) price change was -9.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

MURA is expected to report earnings on May 20, 2025.

NUVB is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVB($845M) has a higher market cap than MURA($68.2M). MURA YTD gains are higher at: 24.224 vs. NUVB (-5.639). MURA has higher annual earnings (EBITDA): -157.66M vs. NUVB (-555.53M). NUVB has more cash in the bank: 549M vs. MURA (176M). MURA has less debt than NUVB: MURA (9.55M) vs NUVB (11.2M). NUVB has higher revenues than MURA: NUVB (2.16M) vs MURA (0).
MURANUVBMURA / NUVB
Capitalization68.2M845M8%
EBITDA-157.66M-555.53M28%
Gain YTD24.224-5.639-430%
P/E RatioN/AN/A-
Revenue02.16M-
Total Cash176M549M32%
Total Debt9.55M11.2M85%
TECHNICAL ANALYSIS
Technical Analysis
MURANUVB
RSI
ODDS (%)
Bullish Trend 11 days ago
86%
Bearish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
85%
Momentum
ODDS (%)
Bullish Trend 11 days ago
86%
Bullish Trend 11 days ago
72%
MACD
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 11 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 11 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
80%
Bullish Trend 11 days ago
80%
Advances
ODDS (%)
Bullish Trend 11 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 24 days ago
83%
Bearish Trend 20 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
Aroon
ODDS (%)
Bearish Trend 11 days ago
76%
N/A
View a ticker or compare two or three
Ad is loading...
MURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MOJAX14.470.10
+0.70%
Donoghue Forlines Momentum A
PUGCX12.900.06
+0.47%
Putnam Focused International Equity C
FDIKX43.020.18
+0.42%
Fidelity Diversified International K
SPMVX9.710.04
+0.41%
Invesco SteelPath MLP Select 40 R5
ANDRX14.000.01
+0.07%
AQR International Defensive Style R6

MURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MURA has been loosely correlated with MGTX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MURA jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MURA
1D Price
Change %
MURA100%
+8.40%
MGTX - MURA
37%
Loosely correlated
+5.56%
NUVB - MURA
36%
Loosely correlated
-1.18%
PRME - MURA
35%
Loosely correlated
+0.70%
BEAM - MURA
34%
Loosely correlated
+0.17%
STRO - MURA
34%
Loosely correlated
+8.65%
More

NUVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with STRO. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then STRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
-1.18%
STRO - NUVB
52%
Loosely correlated
+8.65%
STOK - NUVB
46%
Loosely correlated
-1.06%
VCYT - NUVB
40%
Loosely correlated
-1.27%
KYMR - NUVB
39%
Loosely correlated
+0.79%
VCEL - NUVB
39%
Loosely correlated
+4.83%
More